Early diagnosis of liver cancer risk with non-invasive and painless liver fibrosis scan
Sep 03, 2025
Suncheonhyang University Bucheon Hospital (Hospital Director Moon Jong-ho) diagnoses the risk of liver cancer early through non-invasive and painless liver fibrosis scan instead of invasive liver biopsy.
Liver fibrosis is a condition in which the liver gradually hardens, resulting in a decrease in elasticity and obstruction of blood flow. If left unattended, it can progress to cirrhosis or liver cancer, so accurate diagnosis plays a major role in determining the direction of treatment. Liver biopsy, the existing standard diagnostic method, is an invasive test that requires incision, and it carries the patient's pain and anxiety as well as the rare risk of serious complications.
The liver fibrosis scan test is a method of simultaneously measuring liver elasticity and fat content by sending ultrasonic waves and vibration waves to the patient's right side. There is no need for separate fasting or administration of anesthetics or contrast agents, and the test time is short within 5-10 minutes. In particular, there are no incision, pain, or side effects, so the burden on patients is low.
Soonchunhyang University Bucheon Hospital is operating the latest inspection equipment 'FibroScan 630'. It boasts high accuracy with globally proven standard equipment, and can simultaneously evaluate liver fibrosis and fatty liver. It is also possible to check real-time figures and consult with results.
In a study of chronic hepatitis B patients undergoing antiviral treatment, a team led by Kim Young-seok (Professor Kim Sang-kyun and Yoo Jung-joo) of the Gastroenterology Clinic at Soonchunhyang University Bucheon Hospital proved for the first time in the world that a liver fibrosis scan test can predict the possibility of liver cancer with the same accuracy as a liver biopsy. The results of this study were published in the international journal 『Medicine』, and based on this, the researchers are actively using liver fibrosis scan tests to predict early liver cancer.
Professor Yoo Jeong-ju of Gastroenterology said "The liver fibrosis scan test is a groundbreaking test that can quantify the degree of liver fibrosis without the risk of pain and side effects. Recently, it is essential to evaluate various liver diseases such as cirrhosis, fatty liver, and hepatitis", and "It is difficult to fully recover to normal liver condition once cirrhosis progresses, so it is of paramount importance to prevent liver function impairment and complications through early diagnosis and active management."
Liver fibrosis is a condition in which the liver gradually hardens, resulting in a decrease in elasticity and obstruction of blood flow. If left unattended, it can progress to cirrhosis or liver cancer, so accurate diagnosis plays a major role in determining the direction of treatment. Liver biopsy, the existing standard diagnostic method, is an invasive test that requires incision, and it carries the patient's pain and anxiety as well as the rare risk of serious complications.
The liver fibrosis scan test is a method of simultaneously measuring liver elasticity and fat content by sending ultrasonic waves and vibration waves to the patient's right side. There is no need for separate fasting or administration of anesthetics or contrast agents, and the test time is short within 5-10 minutes. In particular, there are no incision, pain, or side effects, so the burden on patients is low.
Soonchunhyang University Bucheon Hospital is operating the latest inspection equipment 'FibroScan 630'. It boasts high accuracy with globally proven standard equipment, and can simultaneously evaluate liver fibrosis and fatty liver. It is also possible to check real-time figures and consult with results.
In a study of chronic hepatitis B patients undergoing antiviral treatment, a team led by Kim Young-seok (Professor Kim Sang-kyun and Yoo Jung-joo) of the Gastroenterology Clinic at Soonchunhyang University Bucheon Hospital proved for the first time in the world that a liver fibrosis scan test can predict the possibility of liver cancer with the same accuracy as a liver biopsy. The results of this study were published in the international journal 『Medicine』, and based on this, the researchers are actively using liver fibrosis scan tests to predict early liver cancer.
Professor Yoo Jeong-ju of Gastroenterology said "The liver fibrosis scan test is a groundbreaking test that can quantify the degree of liver fibrosis without the risk of pain and side effects. Recently, it is essential to evaluate various liver diseases such as cirrhosis, fatty liver, and hepatitis", and "It is difficult to fully recover to normal liver condition once cirrhosis progresses, so it is of paramount importance to prevent liver function impairment and complications through early diagnosis and active management."
|
This article was translated by Naver AI translator.
